The global DNA repair drugs market is projected to grow from USD 8.3 billion in 2024 to USD 30.5 billion by 2034. This growth reflects a strong compound annual growth rate (CAGR) of 13.9% during the forecast period. In 2024, North America led the market with over 38.8% share, generating USD 3.2 billion in revenue. The market is expanding due to the increasing burden of cancer, rising use of...